651 results on '"PFÖHLER, Claudia"'
Search Results
2. Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
3. Early versus late response to PD-1-based immunotherapy in metastatic melanoma
4. Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial
5. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
6. Nachsorge des Melanoms
7. The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects
8. Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREG
9. Age- and Elicitor-Dependent Characterization of Hymenoptera Venom-Induced Anaphylaxis in Children and Adolescents
10. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
11. Handekzem oder Psoriasis: Aktuelles aus der berufsdermatologischen Kohorte der FB323-Studie
12. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
13. Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
14. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry
15. Characterisation and outcome of RAC1 mutated melanoma
16. Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease
17. CLAUDIUS Study: Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma – A retrospective multicenter study and literature review
18. Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
19. Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
20. S1‐Leitlinie Talgdrüsenkarzinom
21. Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus
22. Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food
23. Risk Factors and Characteristics of Biphasic Anaphylaxis
24. Contact allergies to dental materials in patients.
25. S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.
26. S1‐Guideline Sebaceous Carcinoma.
27. Genetic Association and Differential RNA Expression of Histone (De)Acetylation-Related Genes in Pemphigus Foliaceus—A Possible Epigenetic Effect in the Autoimmune Response
28. Contact allergies to dental materials in patients
29. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
30. Melanoma-Associated Retinopathy
31. Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register
32. Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG
33. PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
34. Melanoma follow-up care
35. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
36. Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
37. Genetic Association and Differential RNA Expression of Histone (De)Acetylation-Related Genes in Pemphigus Foliaceus—A Possible Epigenetic Effect in the Autoimmune Response.
38. Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
39. Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
40. Supplementary Methods, Tables 1 - 2 from Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
41. Data from Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
42. Data from In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group
43. Supplementary Table 1 and Figure 1 from In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group
44. S2k‐Leitlinie – Merkelzellkarzinom – Update 2022
45. S2k Guideline – Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – Update 2022
46. CLAUDIUS Study: Risk of Materno-Fetal Transmission of Melanoma Cells in Pregnant Women with High Grade Melanoma – A Retrospective Multicenter Study and Literature Review
47. S2k Guideline : Merkel cell carcinoma
48. A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes
49. Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
50. Etanercept leads to a rapid recovery of a Dabrafenib‐/Trametinib‐associated toxic epidermal necrolysis‐like severe skin reaction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.